BD HorizonTM BV650 Mouse Anti-Human CD69

Description

Flow cytometric analysis of CD69 expressed on stimulated peripheral blood mononuclear cells. Human PBMC were stimulated for 24 hours with Phytohemagglutinin PHA; Sigma L-1668 . The cells were then stained with either BD Horizon BV650 Mouse IgG1, kappa Isotype control Cat. No. 563231; dashed line histogram or BD Horizon BV650 Mouse Anti-Human CD69 antibody Cat. No. 563835; solid line histogram . The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable activated lymphocytes. Flow cytometric analysis was performed using a BD LSR II Flow Cytometer System. Flow cytometric analysis of CD69 expressed on stimulated peripheral blood mononuclear cells. Human PBMC were stimulated for 24 hours with Phytohemagglutinin PHA; Sigma L-1668 . The cells were then stained with either BD Horizon BV650 Mouse IgG1, kappa Isotype control Cat. No. 563231; dashed line histogram or BD Horizon BV650 Mouse Anti-Human CD69 antibody Cat. No. 563835; solid line histogram . The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable activated lymphocytes. Flow cytometric analysis was performed using a BD LSR II Flow Cytometer System. Show More Flow cytometric analysis of CD69 expressed on stimulated peripheral blood mononuclear cells. Human PBMC were stimulated for 24 hours with Phytohemagglutinin PHA; Sigma L-1668 . The cells were then stained with either BD Horizon BV650 Mouse IgG1, kappa Isotype control Cat. No. 563231; dashed line histogram or BD Horizon BV650 Mouse Anti-Human CD69 antibody Cat. No. 563835; solid line histogram . The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable activated lymphocytes. Flow cytometric analysis was performed using a BD LSR II Flow Cytometer System.